Bromomisonidazole: synthesis and characterization of a new radiosensitizer.
D000818:Animals; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006207:Half-Life; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008920:Misonidazole / Q000031:analogs & derivatives / Q000032:analysis / Q000138:chemical synthesis* / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000532:radiotherapy; D009593:Nitroimidazoles / Q000138:chemical synthesis*; D011838:Radiation-Sensitizing Agents; D014018:Tissue Distribution
D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; C035756:4-bromomisonidazole; D008920:Misonidazole